Copyright Reports & Markets. All rights reserved.

Global Duck Vaccines Market Insights, Forecast to 2025

Request for Sample of this report
Buy now
  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Duck Vaccines Industry
  • 1.7 COVID-19 Impact: Duck Vaccines Market Trends

    • 2 Global Duck Vaccines Quarterly Market Size Analysis

    • 2.1 Duck Vaccines Business Impact Assessment - COVID-19
      • 2.1.1 Global Duck Vaccines Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
      • 2.1.2 Global Duck Vaccines Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global Duck Vaccines Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 Global Duck Vaccines Quarterly Market Size by Manufacturers, 2019 VS 2020
    • 3.2 Global Duck Vaccines Factory Price by Manufacturers
    • 3.3 Location of Key Manufacturers Duck Vaccines Manufacturing Factories and Area Served
    • 3.4 Date of Key Manufacturers Enter into Duck Vaccines Market
    • 3.5 Key Manufacturers Duck Vaccines Product Offered
    • 3.6 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on Duck Vaccines Segments, By Type

    • 4.1 Introduction
      • 1.4.1 Live Vaccines
      • 1.4.2 Killed Vaccines
    • 4.2 By Type, Global Duck Vaccines Market Size, 2019-2021
      • 4.2.1 By Type, Global Duck Vaccines Market Size by Type, 2020-2021
      • 4.2.2 By Type, Global Duck Vaccines Price, 2020-2021

    5 Impact of Covid-19 on Duck Vaccines Segments, By Application

    • 5.1 Overview
      • 5.5.1 Avian Influenza Vaccine
      • 5.5.2 Newcastle Disease Vaccine
      • 5.5.3 Other
    • 5.2 By Application, Global Duck Vaccines Market Size, 2019-2021
      • 5.2.1 By Application, Global Duck Vaccines Market Size by Application, 2019-2021
      • 5.2.2 By Application, Global Duck Vaccines Price, 2020-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 Merial
      • 7.1.1 Merial Business Overview
      • 7.1.2 Merial Duck Vaccines Quarterly Production and Revenue, 2020
      • 7.1.3 Merial Duck Vaccines Product Introduction
      • 7.1.4 Merial Response to COVID-19 and Related Developments
    • 7.2 CEVA
      • 7.2.1 CEVA Business Overview
      • 7.2.2 CEVA Duck Vaccines Quarterly Production and Revenue, 2020
      • 7.2.3 CEVA Duck Vaccines Product Introduction
      • 7.2.4 CEVA Response to COVID-19 and Related Developments
    • 7.3 QYH Biotech
      • 7.3.1 QYH Biotech Business Overview
      • 7.3.2 QYH Biotech Duck Vaccines Quarterly Production and Revenue, 2020
      • 7.3.3 QYH Biotech Duck Vaccines Product Introduction
      • 7.3.4 QYH Biotech Response to COVID-19 and Related Developments
    • 7.4 Ringpu Biology
      • 7.4.1 Ringpu Biology Business Overview
      • 7.4.2 Ringpu Biology Duck Vaccines Quarterly Production and Revenue, 2020
      • 7.4.3 Ringpu Biology Duck Vaccines Product Introduction
      • 7.4.4 Ringpu Biology Response to COVID-19 and Related Developments
    • 7.5 Yebio
      • 7.5.1 Yebio Business Overview
      • 7.5.2 Yebio Duck Vaccines Quarterly Production and Revenue, 2020
      • 7.5.3 Yebio Duck Vaccines Product Introduction
      • 7.5.4 Yebio Response to COVID-19 and Related Developments
    • 7.6 Harbin Veterinary Research Institute
      • 7.6.1 Harbin Veterinary Research Institute Business Overview
      • 7.6.2 Harbin Veterinary Research Institute Duck Vaccines Quarterly Production and Revenue, 2020
      • 7.6.3 Harbin Veterinary Research Institute Duck Vaccines Product Introduction
      • 7.6.4 Harbin Veterinary Research Institute Response to COVID-19 and Related Developments
    • 7.7 Merck Animal Health
      • 7.7.1 Merck Animal Health Business Overview
      • 7.7.2 Merck Animal Health Duck Vaccines Quarterly Production and Revenue, 2020
      • 7.7.3 Merck Animal Health Duck Vaccines Product Introduction
      • 7.7.4 Merck Animal Health Response to COVID-19 and Related Developments
    • 7.8 DHN
      • 7.8.1 DHN Business Overview
      • 7.8.2 DHN Duck Vaccines Quarterly Production and Revenue, 2020
      • 7.8.3 DHN Duck Vaccines Product Introduction
      • 7.8.4 DHN Response to COVID-19 and Related Developments
    • 7.9 Zoetis
      • 7.9.1 Zoetis Business Overview
      • 7.9.2 Zoetis Duck Vaccines Quarterly Production and Revenue, 2020
      • 7.9.3 Zoetis Duck Vaccines Product Introduction
      • 7.9.4 Zoetis Response to COVID-19 and Related Developments
    • 7.10 ChengDu Tecbond
      • 7.10.1 ChengDu Tecbond Business Overview
      • 7.10.2 ChengDu Tecbond Duck Vaccines Quarterly Production and Revenue, 2020
      • 7.10.3 ChengDu Tecbond Duck Vaccines Product Introduction
      • 7.10.4 ChengDu Tecbond Response to COVID-19 and Related Developments
    • 7.11 Elanco (Lohmann)
      • 7.11.1 Elanco (Lohmann) Business Overview
      • 7.11.2 Elanco (Lohmann) Duck Vaccines Quarterly Production and Revenue, 2020
      • 7.11.3 Elanco (Lohmann) Duck Vaccines Product Introduction
      • 7.11.4 Elanco (Lohmann) Response to COVID-19 and Related Developments
    • 7.12 FATRO
      • 7.12.1 FATRO Business Overview
      • 7.12.2 FATRO Duck Vaccines Quarterly Production and Revenue, 2020
      • 7.12.3 FATRO Duck Vaccines Product Introduction
      • 7.12.4 FATRO Response to COVID-19 and Related Developments
    • 7.13 CAVAC
      • 7.13.1 CAVAC Business Overview
      • 7.13.2 CAVAC Duck Vaccines Quarterly Production and Revenue, 2020
      • 7.13.3 CAVAC Duck Vaccines Product Introduction
      • 7.13.4 CAVAC Response to COVID-19 and Related Developments
    • 7.14 Vaksindo
      • 7.14.1 Vaksindo Business Overview
      • 7.14.2 Vaksindo Duck Vaccines Quarterly Production and Revenue, 2020
      • 7.14.3 Vaksindo Duck Vaccines Product Introduction
      • 7.14.4 Vaksindo Response to COVID-19 and Related Developments

    8 Supply Chain and Sales Channels Analysis

    • 8.1 Duck Vaccines Supply Chain Analysis
      • 8.1.1 Duck Vaccines Supply Chain Analysis
      • 8.1.2 Covid-19 Impact on Duck Vaccines Supply Chain
    • 8.2 Distribution Channels Analysis
      • 8.2.1 Duck Vaccines Distribution Channels
      • 8.2.2 Covid-19 Impact on Duck Vaccines Distribution Channels
      • 8.2.3 Duck Vaccines Distributors
    • 8.3 Duck Vaccines Customers

    9 Key Findings

      10 Appendix

      • 10.1 About Us

      This report covers market size and forecasts of Duck Vaccines, including the following market information:
      Global Duck Vaccines Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (Units)
      Global Duck Vaccines Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (Units)
      Global Duck Vaccines Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (Units)
      Global Duck Vaccines Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (Units)

      Key market players
      Major competitors identified in this market include Merial, CEVA, QYH Biotech, Ringpu Biology, Yebio, Harbin Veterinary Research Institute, Merck Animal Health, DHN, Zoetis, ChengDu Tecbond, Elanco (Lohmann), FATRO, CAVAC, Vaksindo, etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      Live Vaccines
      Killed Vaccines

      Based on the Application:
      Avian Influenza Vaccine
      Newcastle Disease Vaccine
      Other

      Buy now